Why the study?
Is gray matter T2-hypointensity on brain MRI associated with clinical progression in patients with multiple sclerosis?
Is gray matter T2-hypointensity on brain MRI associated with clinical progression in patients with multiple sclerosis?
Gray matter T2-hypointensity on MRI may serve as a clinically relevant marker of neurodegeneration and disease progression in multiple sclerosis.
May mark MS progression; hypothesis-generating and requires prospective validation before clinical adoption.
No takes yet. Share an insight, caveat, or question.
Neema et al. (2009) studied this question.